1. Home
  2. Product Information
  3. Motilin Receptor Agonist

Product Information

Motilin Receptor Agonist

Compound Code RQ-00201894
Primary Target Indications Functional Dyspepsia
Development Stage Discovery research
Portfolio for global development, manufacturing, and marketing rights
Product Summary Motilin, one of the digestive tract peptides, is involved in controlling the workings of the gastrointestinal tract when the stomach is empty. Motilin receptor agonists have the effect of promoting the emptying of the stomach and accelerating the motility of the gastrointestinal tract. It is hoped that it can become a treatment for diseases caused by abnormal gastrointestinal tract motility, such as gastro-esophageal reflux disease. We at RaQualia are pursuing projects to find a low-molecule-compound motilin agonist, and we are working to confirm effectiveness in accelerating gastrointestinal tract motility in animal models using our lead compound(s).
Non-Confidential Materials

Motilin Receptor Agonist (155KB)

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Facilities
Access
Press Release
Research & Development
Collaboration
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Anidulafungin
Ziprasidone
Dalbavancin
EP4 Antagonist
Cyclooxygenase-2 (COX-2) Inhibitor
Ghrelin Receptor Agonist
5-HT4 Partial Agonist
Acid Pump Antagonist
5-HT2B Antagonist
CB2 Agonist
Motilin Receptor Agonist
Licensing
Shareholder and Investor Information
To our Shareholders and Investors
Vision, Management Principle and Culture
Corporate Governance
Stock Quotes
Outline of Securities Matters
IR Library
IR Calendar
Disclaimer
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Corporate Introduction Video
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release
Topics